Computational Psychiatry: EEG key for the future mental health scape.
Artificial intelligence combined with the latest neuroscientific findings offer alternatives to improve both patient outcomes and treatment of brain disorders with a new perspective. The use of objective cerebral metrics, such as EEG or brain wave monitoring, will shape the future of the mental health scape.
The benefits of collecting EEG neuroimaging insights in clinical trials.
In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective and repeatable data enabling a deeper understanding of the pharmacological effects of the drug early in its development.
myBrain Technologies’s eye on Medical Device Regulation.
In order to improve health safety and harmonize rules within the EU, the Medical Device Regulation has been profoundly revised, resulting in new regulatory requirements - effective from May 26, 2021. To understand the difficulties of its application by manufacturers and find solutions, we interviewed Sophie Colliot.
Computational Psychiatry: how neurotechnology is changing the world of mental health ?
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.
The path to ISO 13485.
Implementing a quality approach within a start-up poses particular difficulties linked to the context of innovation, agility and rapid growth. However, such an approach is essential to guarantee the sustainability of its activities and to enable it to become a leader in its market.
